Does AMIODARONE Cause Hepatic cytolysis? 100 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Hepatic cytolysis have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 0.4% of all adverse event reports for AMIODARONE.
100
Reports of Hepatic cytolysis with AMIODARONE
0.4%
of all AMIODARONE reports
0
Deaths
71
Hospitalizations
How Dangerous Is Hepatic cytolysis From AMIODARONE?
Of the 100 reports, 71 (71.0%) required hospitalization, and 11 (11.0%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does AMIODARONE Cause?
Drug ineffective (2,223)
Dyspnoea (2,182)
Off label use (1,608)
Drug interaction (1,589)
Asthenia (1,452)
Interstitial lung disease (1,421)
Hyperthyroidism (1,410)
Fatigue (1,269)
Bradycardia (1,261)
Atrial fibrillation (1,211)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which AMIODARONE Alternatives Have Lower Hepatic cytolysis Risk?
AMIODARONE vs AMISULPRIDE
AMIODARONE vs AMITRIPTYLINE
AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE
AMIODARONE vs AMIVANTAMAB
AMIODARONE vs AMIVANTAMAB-VMJW